News
Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...
Pharming Group N.V. ("Pharming” or "the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback